Stay updated on Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.

Latest updates to the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page
- Check5 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRemoved the 403 Forbidden content from the study page, allowing the study details to load and be viewed by users.SummaryDifference0.5%

- Check26 days agoChange DetectedThe study page now presents a 403 Forbidden error page instead of the study details, showing the site’s standard layout with a 403 message and a Home button. This indicates access to the study record is blocked or the page failed to load.SummaryDifference17%

- Check47 days agoChange DetectedThe page revision tag was updated to v3.6.6, replacing the previous v3.6.5, indicating a maintenance update to the study page with no substantive changes to study information.SummaryDifference0.1%

- Check68 days agoChange DetectedThe footer now displays Revision: v3.6.5, replacing the previous v3.6.4. This reflects a minor maintenance update to the site.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a deployment update; the visible study information remains unchanged.SummaryDifference0.1%

Stay in the know with updates to Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.